Lumida
/ALMS
⌘K
Alumis Inc

Alumis Inc

ALMS
$9.80USD-7.37%-0.78 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$10 – $11

52W RANGE

$4
$31

AI Summary

Stalk
StalkMedium

ALMS has completed a post-capitulation flush and is forming a base around the $10.50 pivot. Extreme oversold readings and the mean-reversion Post-Capitulation pattern support a bullish medium-term bias, but price remains well below key EMAs. Deferred accumulation in the $10–$12 area is advised until stabilization and a reclaim of short-term EMAs confirms renewed demand.

  • Envudeucitinib ONWARD3 trial: 75% PASI 90 & 54% PASI 100 at 48 weeks
  • $502.3M cash & equivalents support operations into Q4 2027
  • Q2 2026 revenue $1.7M down 37% YoY vs. $3.47M consensus
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income